Virtual Incision

is on a mission to simplify robotic-assisted surgery (RAS), so more patients and their surgeons can access its benefits every day.

Headquartered in Lincoln, Nebraska, and holding over 200 patents and patent applications, the company is developing MIRA, the first-of-its-kind miniature, and highly accessible RAS platform. With MIRA, our goal is to make every operating room RAS-ready.

MIRA is currently in FDA clinical trials under an Investigational Device Exemption (IDE) and is being studied first for bowel resection, with additional potential applications to follow.

Virtual Incision was founded by Shane Farritor, PhD, MS, and Dmitry Oleynikov, MD, FACS, who combined their NASA engineering and minimally invasive surgery (MIS) experience to create MIRA, a small, sleek RAS platform that brings a whole lot to the table.

Company Values

We are grounded in clinical excellence. We are problem solvers focused on patients and customers as our first priority.

We continuously make and improve. We have the curiosity, passion, and conviction to try new things—and look for ways to make them better.

We are authentic. We are transparent because it’s the right thing to do.

We win together. We don’t take ourselves too seriously, just our mission. We respect, trust, challenge and support each other with a common sense of purpose.

We own our destiny. We set ambitious goals, take accountability, and get things done.

The MIRA Evolution

Virtual Incision Senior Leadership Team

John Murphy, CEO Headshot Transparent Background

John Murphy MBA, MS

Chief Executive Officer

John Murphy, M.B.A., M.S., is a global medical technology and health sciences executive who has held leadership roles in large public companies, middle-market private equity businesses, and venture capital environments over the past 30 years. Given his former industry roles as CEO, COO, Director, and Investor, he has extensive experience in technology development for robotic and minimally invasive surgery. He holds graduate and undergraduate degrees in computer science and an MBA in international finance

Shane Farritor, CTO Headshot Transparent Background

Shane Farritor PhD, MS

Co-Founder & Chief Technology Officer

Shane Farritor, Ph.D., M.S., holds a doctorate and master’s degree in Mechanical Engineering from MIT and is currently a faculty member at the University of Nebraska-Lincoln. Prior to his work at the university, Shane studied at the Kennedy Space Center, Goddard Space Flight Center, and the Jet Propulsion Laboratory.  Shane holds over 170 patents and has published over 140 peer-reviewed articles in the field of robotics.

Dmitry Oleynikov, CMO Headshot Transparent Background

Dmitry Oleynikov MD, FACS

Co-Founder & Chief Medical Officer

Dmitry Oleynikov, M.D., F.A.C.S., is an active general, esophageal, and minimally invasive surgeon. As a Clinical Professor of Surgery, he has authored over 200 peer-reviewed articles, and he holds over 25 patents in the area of surgical robotics. The Society of American Gastrointestinal and Endoscopic Surgeons has recognized him for his achievements with an award in Excellence in Leadership.  He currently serves as Chair of Surgery at RWJ Monmouth Medical Center and Professor of Surgery at RWJ Rutgers University Medical School.

Mukund Srinivasan, CFO Headshot Transparent Background

Mukund Srinivasan PhD, MBA

Chief Financial Officer

Mukund Srinivasan, Ph.D., M.B.A, is a seasoned Finance Executive and Board Advisor in varied industries such as semiconductors, services, and med-tech.  He received a Ph.D. in Engineering from the Johns Hopkins University and was a Post-Doctoral Fellow at Princeton University.  He has held leadership roles in both public and private companies as the VP of Finance, VP of FP&A, and Corporate Controller / Principal Accounting Officer.  Mukund has presided over significant fund raising as well as mergers and divestitures.

Virtual Incision in the News

John Murphy, CEO Headshot Transparent Background

Medsider Interview with John Muphy

| Recent News | No Comments
Planning Your Regulatory Pathway Around Your Product Roadmap: Interview with Virtual Incision CEO John Murphy Recently, Virtual Incision CEO John Murphy was featured on the Medsider Podcast with Scott Nelson.…
Virtual Incision IDE

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

| Press Release | No Comments
FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized…
VIC $46 Million Financing Featured Image

Virtual Incision Announces $46 Million Financing to Advance First-of-its-Kind MIRA Surgical Platform.

| Press Release | No Comments
IDE clinical study of robotic-assisted MIRA Surgical Platform currently underway for laparoscopic colon surgery (more…)